We critically examine evidence demonstrating how specific flavonoids, terpenoids, and alkaloids simultaneously disrupt multiple cancer hallmarks-including aberrant PI3K/Akt/mTOR signaling, cell cycle progression, and the pro-tumorigenic microenvironment-thereby preventing compensatory pathway activation. The gene discussed is AKT1; the disease is cancer.